KIVU-107 is an experimental antibody-drug conjugate from Kivu Bioscience, in phase 1 trials for advanced solid tumours.
KIVU-107 is an antibody-drug conjugate (site-specific, GlycoConnect and HydraSpace) from Kivu Bioscience. An antibody-drug conjugate against PTK7, built with site-specific GlycoConnect and HydraSpace conjugation for a precise, stable drug-to-antibody ratio. Its furthest stage is phase 1, for advanced solid tumours. ClinicalTrials.gov registers it in one study linked below. Whether it works in people has not been established unless a trial below reports it.
An antibody-drug conjugate against PTK7, built with site-specific GlycoConnect and HydraSpace conjugation for a precise, stable drug-to-antibody ratio. Connects to PTK7.
1.KIVU-107's antibody arm binds PTK7 on the surface of the cancer cell.
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"KIVU-107" OR ABSTRACT:"KIVU-107") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about KIVU-107, not a curated reading list.
Shares Kivu Bioscience, Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Kivu Bioscience, Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/